<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04063436</url>
  </required_header>
  <id_info>
    <org_study_id>CIA-264</org_study_id>
    <nct_id>NCT04063436</nct_id>
  </id_info>
  <brief_title>Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea</brief_title>
  <official_title>Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is designed to evaluate the performance, comfort, and usability of a new
      nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in a home environment.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Clinical trial was cancelled
  </why_stopped>
  <start_date type="Anticipated">September 23, 2019</start_date>
  <completion_date type="Anticipated">October 11, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>After the baseline period, all participants will be trialed on the same new nasal pillows mask.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Performance of new nasal pillows mask</measure>
    <time_frame>14±5 days</time_frame>
    <description>The new nasal pillows mask provides adequate PAP therapy for OSA when used in a home environment. This is an objective measure and is determined by the Apnea-Hypopnea Index recorded on PAP therapy machines.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort of new nasal pillows mask</measure>
    <time_frame>14±5 days</time_frame>
    <description>The new nasal pillows mask is comfortable during PAP therapy for OSA when used in a home environment. This is a subjective measure and is determined by a five-point Likert-type scale as recorded on a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Usability of new nasal pillows mask</measure>
    <time_frame>14±5 days</time_frame>
    <description>The new nasal pillows mask is user-friendly during PAP therapy for OSA when used in a home environment. This is a subjective measure and is determined by a five-point Likert-type scale as recorded on a questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be placed in the experimental arm for 14±5 days, during which they will be using the new nasal pillows mask for PAP therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>New nasal pillows mask with PAP therapy</intervention_name>
    <description>Participants will be placed in the experimental arm for 14±5 days, during which they will be using the new nasal pillows mask for PAP therapy.</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are ≥22 years of age

          -  Weigh ≥66 lbs

          -  Have been formally diagnosed with OSA by a physician

          -  Have an AHI ≥5 on a diagnostic night

          -  Have been prescribed PAP therapy to treat OSA by a physician

          -  Are an existing nasal pillows mask user

          -  Have been using a nasal pillows mask for ≥3 months prior to enrolment into the study

          -  Are compliant with PAP therapy for ≥4 hours per night for 70% of nights

          -  Are fluent in spoken and written English

          -  Possess the capacity to provide informed consent

        Exclusion Criteria:

          -  Are intolerant to PAP therapy

          -  Possess, or suffer from, anatomical or physiological conditions which make PAP therapy
             inappropriate

          -  Are currently diagnosed with respiratory disease or CO2 retention

          -  Are pregnant or think they may be pregnant

          -  Have an IPAP pressure of &gt;25 cmH2O

          -  Persons who use a PAP therapy machine for the delivery of medicines, except O2

          -  Use a PAP therapy machine that does not possess data recording capabilities to capture
             AHI and leak information that is accessible to OSMI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ohio Sleep Medicine Institute</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 13, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2019</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

